A5050018487- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Blood Pressure and Hypertension Studies
- Healthcare Systems and Practices
- Acute Kidney Injury Research
- Neurological Complications and Syndromes
- Medication Adherence and Compliance
- Renal and Vascular Pathologies
- Health, Medicine and Society
- Diet and metabolism studies
- Blood disorders and treatments
- Heparin-Induced Thrombocytopenia and Thrombosis
- Diabetes Treatment and Management
- Muscle and Compartmental Disorders
- Chronic Disease Management Strategies
- Pharmaceutical Economics and Policy
- Renal Diseases and Glomerulopathies
- Health Systems, Economic Evaluations, Quality of Life
- Platelet Disorders and Treatments
- Pharmaceutical Practices and Patient Outcomes
Institut Desbrest d'Epidémiologie et de Santé Publique
2023
Inserm
2022-2023
Université de Nîmes
2021-2023
Centre Hospitalier Universitaire de Nîmes
2019-2022
Institut Universitaire de Recherche Clinique
2019-2022
Université de Montpellier
2019
A middle-aged woman with history of antiphospholipid syndrome, admitted to our hospital for lethargy and persistent chest pain, developed during hospitalisation intracerebral transverse sinus sigmoid vein thromboses, retinal acute renal failure cardiac involvement associated thrombocytopaenia. Diagnosis catastrophic syndrome was made treated IV steroids, heparin infusion double filtration plasmapheresis (DFPP) without fresh frozen plasma. Heparin-induced thrombocytopaenia second diagnosed...
Abstract Background and Aims Chronic kidney disease (CKD) is a common with heterogeneous course. The Kidney Failure Risk Equation (KFRE) designed to predict 5-year End stage renal (ESRD). This score has shown poor performance in predicting 5-years ESRD elderly patients, probably because of competitive risk death. Indeed, patients type 2 diabetes are numerous older than non-diabetic higher risks death, thus à risk. In this context, we aimed evaluate the KFRE at 5 years, cohort from tertiary...
Abstract Background and Aims Standard intermittent haemodialysis (SIHD) includes anticoagulation to avoid clotting of the dialysis system. In patients at high risk for bleeding, alternativ methods have been developed systemic anticoagulation. Regional citrate (RCA) is usually used with continuous renal replacement therapy low blood flow but Promotheus® device (Freseinus Medical care-Germany) allow RCA liver support system 4008H® over 200ml/min. The aim this study was compare IHD (IHD-RCA)...